Recent advances in microfluidic technology of arterial thrombosis investigations
In conclusion, microfluidic technology has revolutionized the study of arterial thrombosis by enabling the construction of artificial blood vessels and accurately reproducing hemodynamics. In the future, microfluidics will place greater emphasis on versatility and automation, holding great promise for advancing antithrombotic therapeutic and prophylactic measures.PMID:38390892 | DOI:10.1080/09537104.2024.2316743 (Source: Platelets)
Source: Platelets - February 23, 2024 Category: Hematology Authors: Jingying Lin Si Chen Chunying Zhang Juan Liao Yuemei Chen Shanying Deng Zhigang Mao Tonghao Zhang Na Tian Yali Song Tingting Zeng Source Type: research
Platelet rich fibrin as a bioactive matrix with proosteogenic and proangiogenic properties on human healthy primary cells in vitro
In conclusion, PRF possess proosteogenic, potentially osteoconductive as well as proangiogenic properties, making it a beneficial tool for bone tissue regeneration.PMID:38390838 | DOI:10.1080/09537104.2024.2316744 (Source: Platelets)
Source: Platelets - February 23, 2024 Category: Hematology Authors: Eva Dohle Lena Schmeinck Kamelia Parkhoo Robert Sader Shahram Ghanaati Source Type: research
Recent advances in microfluidic technology of arterial thrombosis investigations
In conclusion, microfluidic technology has revolutionized the study of arterial thrombosis by enabling the construction of artificial blood vessels and accurately reproducing hemodynamics. In the future, microfluidics will place greater emphasis on versatility and automation, holding great promise for advancing antithrombotic therapeutic and prophylactic measures.PMID:38390892 | DOI:10.1080/09537104.2024.2316743 (Source: Platelets)
Source: Platelets - February 23, 2024 Category: Hematology Authors: Jingying Lin Si Chen Chunying Zhang Juan Liao Yuemei Chen Shanying Deng Zhigang Mao Tonghao Zhang Na Tian Yali Song Tingting Zeng Source Type: research
Platelet rich fibrin as a bioactive matrix with proosteogenic and proangiogenic properties on human healthy primary cells in vitro
In conclusion, PRF possess proosteogenic, potentially osteoconductive as well as proangiogenic properties, making it a beneficial tool for bone tissue regeneration.PMID:38390838 | DOI:10.1080/09537104.2024.2316744 (Source: Platelets)
Source: Platelets - February 23, 2024 Category: Hematology Authors: Eva Dohle Lena Schmeinck Kamelia Parkhoo Robert Sader Shahram Ghanaati Source Type: research
Recent advances in microfluidic technology of arterial thrombosis investigations
In conclusion, microfluidic technology has revolutionized the study of arterial thrombosis by enabling the construction of artificial blood vessels and accurately reproducing hemodynamics. In the future, microfluidics will place greater emphasis on versatility and automation, holding great promise for advancing antithrombotic therapeutic and prophylactic measures.PMID:38390892 | DOI:10.1080/09537104.2024.2316743 (Source: Platelets)
Source: Platelets - February 23, 2024 Category: Hematology Authors: Jingying Lin Si Chen Chunying Zhang Juan Liao Yuemei Chen Shanying Deng Zhigang Mao Tonghao Zhang Na Tian Yali Song Tingting Zeng Source Type: research
Platelet rich fibrin as a bioactive matrix with proosteogenic and proangiogenic properties on human healthy primary cells in vitro
In conclusion, PRF possess proosteogenic, potentially osteoconductive as well as proangiogenic properties, making it a beneficial tool for bone tissue regeneration.PMID:38390838 | DOI:10.1080/09537104.2024.2316744 (Source: Platelets)
Source: Platelets - February 23, 2024 Category: Hematology Authors: Eva Dohle Lena Schmeinck Kamelia Parkhoo Robert Sader Shahram Ghanaati Source Type: research
Recent advances in microfluidic technology of arterial thrombosis investigations
In conclusion, microfluidic technology has revolutionized the study of arterial thrombosis by enabling the construction of artificial blood vessels and accurately reproducing hemodynamics. In the future, microfluidics will place greater emphasis on versatility and automation, holding great promise for advancing antithrombotic therapeutic and prophylactic measures.PMID:38390892 | DOI:10.1080/09537104.2024.2316743 (Source: Platelets)
Source: Platelets - February 23, 2024 Category: Hematology Authors: Jingying Lin Si Chen Chunying Zhang Juan Liao Yuemei Chen Shanying Deng Zhigang Mao Tonghao Zhang Na Tian Yali Song Tingting Zeng Source Type: research
Platelet rich fibrin as a bioactive matrix with proosteogenic and proangiogenic properties on human healthy primary cells in vitro
In conclusion, PRF possess proosteogenic, potentially osteoconductive as well as proangiogenic properties, making it a beneficial tool for bone tissue regeneration.PMID:38390838 | DOI:10.1080/09537104.2024.2316744 (Source: Platelets)
Source: Platelets - February 23, 2024 Category: Hematology Authors: Eva Dohle Lena Schmeinck Kamelia Parkhoo Robert Sader Shahram Ghanaati Source Type: research
Recent advances in microfluidic technology of arterial thrombosis investigations
In conclusion, microfluidic technology has revolutionized the study of arterial thrombosis by enabling the construction of artificial blood vessels and accurately reproducing hemodynamics. In the future, microfluidics will place greater emphasis on versatility and automation, holding great promise for advancing antithrombotic therapeutic and prophylactic measures.PMID:38390892 | DOI:10.1080/09537104.2024.2316743 (Source: Platelets)
Source: Platelets - February 23, 2024 Category: Hematology Authors: Jingying Lin Si Chen Chunying Zhang Juan Liao Yuemei Chen Shanying Deng Zhigang Mao Tonghao Zhang Na Tian Yali Song Tingting Zeng Source Type: research
Development of a super-hydrophilic anaerobic tube for the optimization of platelet-rich fibrin
In conclusion, the newly modified PRF tubes had better platelet activation properties leading to better mechanical strength, a longer degradation period, and better regenerative properties in oral cell types including gingival fibroblast and alveolar osteoblasts. It also improves the success rate of H-PRF preparation in patients with coagulation dysfunction and expands the clinical application scenario.PMID:38385327 | DOI:10.1080/09537104.2024.2316745 (Source: Platelets)
Source: Platelets - February 22, 2024 Category: Hematology Authors: Yan Wei Yihong Cheng Hongjiang Wei Yulan Wang Xiaoxin Zhang Richard J Miron Yufeng Zhang Shanglan Qing Source Type: research
Increased circulating platelet-derived extracellular vesicles in severe COVID-19 disease
Platelets. 2024 Dec;35(1):2313362. doi: 10.1080/09537104.2024.2313362. Epub 2024 Feb 21.ABSTRACTCoagulation disturbances are major contributors to COVID-19 pathogenicity, but limited data exist on the involvement of extracellular vesicles (EVs) and residual cells (RCs). Fifty hospitalized COVID-19 patients stratified by their D-dimer levels into high (>1.5 mg/L, n = 15) or low (≤1.5 mg/l, n = 35) and 10 healthy controls were assessed for medium-sized EVs (mEVs; 200-1000 nm) and large EVs/RCs (1000-4000 nm) by high sensitivity flow cytometry. EVs were analyzed for CD61, CD235a, CD45, and CD31, commonly used to detect p...
Source: Platelets - February 21, 2024 Category: Hematology Authors: Tuukka Helin Mari Palviainen Marja Lemponen Katariina Maaninka Pia Siljander Lotta Joutsi-Korhonen Source Type: research
Glycan-Lectin interactions between platelets and tumor cells drive hematogenous metastasis
Platelets. 2024 Dec;35(1):2315037. doi: 10.1080/09537104.2024.2315037. Epub 2024 Feb 19.ABSTRACTGlycosylation is a ubiquitous cellular or microenvironment-specific post-translational modification that occurs on the surface of normal cells and tumor cells. Tumor cell-associated glycosylation is involved in hematogenous metastasis. A wide variety of tumors undergo aberrant glycosylation to interact with platelets. As platelets have many opportunities to engage circulating tumor cells, they represent an important avenue into understanding the role glycosylation plays in tumor metastasis. Platelet involvement in tumor metastas...
Source: Platelets - February 19, 2024 Category: Hematology Authors: Longqiang Shu Shanyi Lin Shumin Zhou Ting Yuan Source Type: research
